K2, a synthetic substance marketed to young adults for its alleged ability to mimic the effect of cannabis, has become a growing concern for toxicologists and emergency room physicians across the county. Christopher Rosenbaum, MD, a toxicologist and an expert on K2, has seen first-hand the effects that K2 can have on patients. Read the full article.